150 related articles for article (PubMed ID: 8508165)
21. Comparative in vitro sensitivity to metronidazole of Trichomonas vaginalis with isolates and clones.
Sithithaworn P; Sithithaworn J; Kitjaroen K; Pairojkul C; Ratananurakpong S; Sriswangwonk T
Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):279-84. PubMed ID: 2609217
[TBL] [Abstract][Full Text] [Related]
22. The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
Leitsch D; Kolarich D; Duchêne M
Mol Biochem Parasitol; 2010 May; 171(1):17-24. PubMed ID: 20093143
[TBL] [Abstract][Full Text] [Related]
23. Metronidazole-resistant clinical isolates of Trichomonas vaginalis have lowered oxygen affinities.
Yarlett N; Yarlett NC; Lloyd D
Mol Biochem Parasitol; 1986 May; 19(2):111-6. PubMed ID: 3487729
[TBL] [Abstract][Full Text] [Related]
24. [Metronidazole resistance test in vitro in strains of Trichomonas vaginalis isolated from clinical material. 2. Proposal for a standard tests].
Tachezy J; Kulda J
Cesk Epidemiol Mikrobiol Imunol; 1991 Mar; 40(2):97-104. PubMed ID: 1827367
[TBL] [Abstract][Full Text] [Related]
25. Drug targets and mechanisms of resistance in the anaerobic protozoa.
Upcroft P; Upcroft JA
Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
[TBL] [Abstract][Full Text] [Related]
26. Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica.
Samarawickrema NA; Brown DM; Upcroft JA; Thammapalerd N; Upcroft P
J Antimicrob Chemother; 1997 Dec; 40(6):833-40. PubMed ID: 9462435
[TBL] [Abstract][Full Text] [Related]
27. Influence of oxygen on the fermentative metabolism of metronidazole-sensitive and resistant strains of Trichomonas vaginalis.
Ellis JE; Cole D; Lloyd D
Mol Biochem Parasitol; 1992 Nov; 56(1):79-88. PubMed ID: 1475004
[TBL] [Abstract][Full Text] [Related]
28. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
[TBL] [Abstract][Full Text] [Related]
29. Effect of fixation on activity and cytochemistry of hydrogenosomal enzymes in Trichomonas vaginalis.
Goosen NK; Broers CA; Hombergen EJ; Stumm CK; Vogels GD
J Gen Microbiol; 1990 Nov; 136(11):2189-93. PubMed ID: 1706759
[TBL] [Abstract][Full Text] [Related]
30. Use of Trichomonas vaginalis clinical isolates to evaluate correlation of gene expression and metronidazole resistance.
Mead JR; Fernadez M; Romagnoli PA; Secor WE
J Parasitol; 2006 Feb; 92(1):196-9. PubMed ID: 16629339
[TBL] [Abstract][Full Text] [Related]
31. Metabolic differences between metronidazole resistant and susceptible strains of Tritrichomonas foetus.
Cerkasovová A; Cerkasov J; Kulda J
Mol Biochem Parasitol; 1984 Apr; 11():105-18. PubMed ID: 6379446
[TBL] [Abstract][Full Text] [Related]
32. [In vitro studies on the identification of metronidazole resistant strains of Trichomonas vaginalis (author's transl)].
Meingassner JG; Stockinger K
Z Hautkr; 1981 Jan; 56(1):7-15. PubMed ID: 6971538
[TBL] [Abstract][Full Text] [Related]
33. Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance.
Leitsch D; Kolarich D; Binder M; Stadlmann J; Altmann F; Duchêne M
Mol Microbiol; 2009 Apr; 72(2):518-36. PubMed ID: 19415801
[TBL] [Abstract][Full Text] [Related]
34. Measuring the in vitro susceptibility of Trichomonas vaginalis to metronidazole: a disk broth method.
Smith RF; Di Domenico A
Sex Transm Dis; 1980; 7(3):120-4. PubMed ID: 6969450
[TBL] [Abstract][Full Text] [Related]
35. Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates.
Korosh T; Bujans E; Morada M; Karaalioglu C; Vanden Eynde JJ; Mayence A; Huang TL; Yarlett N
Chem Biol Drug Des; 2017 Oct; 90(4):489-495. PubMed ID: 28296056
[TBL] [Abstract][Full Text] [Related]
36. Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.
Kulda J; Vojtĕchovská M; Tachezy J; Demes P; Kunzová E
Br J Vener Dis; 1982 Dec; 58(6):394-9. PubMed ID: 6983379
[TBL] [Abstract][Full Text] [Related]
37. Reduction of niridazole by metronidazole resistant and susceptible strains of Trichomonas vaginalis.
Yarlett N; Rowlands CC; Yarlett NC; Evans JC; Lloyd D
Parasitology; 1987 Feb; 94 ( Pt 1)():93-9. PubMed ID: 3029651
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
[TBL] [Abstract][Full Text] [Related]
39. Metronidazole radical anion generation in vivo in Trichomonas vaginalis: oxygen quenching is enhanced in a drug-resistant strain.
Lloyd D; Pedersen JZ
J Gen Microbiol; 1985 Jan; 131(1):87-92. PubMed ID: 2985740
[TBL] [Abstract][Full Text] [Related]
40. Purification and characterization of pyruvate: ferredoxin oxidoreductase from the anaerobic protozoon Trichomonas vaginalis.
Williams K; Lowe PN; Leadlay PF
Biochem J; 1987 Sep; 246(2):529-36. PubMed ID: 3500709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
